Skip to main content

Jocelyn W. Sun

Associate

[email protected]

+1.858.314.1891

Share:

Jocelyn focuses her practice on general corporate matters, including governance, mergers and acquisitions, and other corporate transactions. She works with companies in a variety of industries, including real estate and financial services.

Prior to joining Mintz, Jocelyn served as a legal intern at a leading San Francisco law firm, conducting due diligence for corporate and real estate acquisition deals and writing memoranda for corporate, tax, and estate planning issues.

While earning her JD, Jocelyn served as editor-in-chief for the Pacific Basin Law Journal and was a member of the Asian and Pacific Islander Law Student Association and the Business Law Association.

News & Press

Press Release Thumbnail Mintz

Mintz advised the underwriters in connection with a $230 million public offering by Cogent Biosciences, Inc. of 25,555,556 shares of common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses.

Press Release Thumbnail Mintz

Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“ 

Read less